|
|
Pre Conference Summit:
1 December 2009 9am - 5pm
Day 1
2 December 2009 9am - 5pm
Day 2
3 December 2009 9am - 5pm
Post Conference Masterclass:
4 December 2009 9am - 5pm
› Full conference programme
|
 Dr Theodore Torphy,
Chief Scientific Officer & Head External Research & Early Development,
Johnson & Johnson, United States
 Mr Murtaza Khorakiwala,
Managing Director,
Wockhardt, India
 Dr Tsutomu Une,
Chairman of the Board,
Ranbaxy Laboratories,
Member of the Board, Senior Executive Officer of Corporate Strategy, Daiichi Sankyo, Japan
 Dr M.K. Bhan,
Secretary, Ministry of Science & Technology, Department of Biotechnology,
Government of India, India
 Dr Rayasam (Ray) Prasad,
Chief Operating Officer - Global (Biologics),
Biological E. Limited, India
Dr Lee E. Babiss,
President & Global Head of Research,
F. Hoffmann-La Roche, Inc, Switzerland |
|
|
|
bioLOGIC India 2009
bioLOGIC India will bring together international and local biologic manufacturers, start-up & spinoff biotechs, research and academic institutions, CROs, CMOs, technology and solution providers, and investors to discuss latest business opportunities, partnership & outsourcing trends, R&D innovation, drug development strategies, and cost-effective manufacturing methodologies in India
|
For delegates
Meet ALL the major players from INDIA’s biopharmaceutical industry
Join 35+ GLOBAL biopharmaceutical key leaders and 20+ India biotechs as they discuss future collaborations
Find out what India’s top CROs and CMOs have to offer to suit your business needs in Asia
Register now and be at the most strategic and comprehensive conference for India and global pharmaceutical industry - bioLOGIC India 2009!
|
|
Special Showcase opportunity for Asian
CRAMS Company (Limited to 6)
Call us to discuss your potential involvement in:
- Podium presentation showcase opportunity in the conference
- Company showcase booth adjacent to the
conference room
- Branding + Profiling by riding on our extensive 5 month Marketing campaign
|
Network and make new contacts
with industry peers
|
|
|
|
|
special delegate pricing for India based biopharmaceuticals
*Terrapinn reserves the right to determine eligibility to special rates.
|
|
|
|
|
